Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 7 trials

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
P 4 (1)

Trial Status

Recruiting4
Unknown2
Not Yet Recruiting1

Clinical Trials (7)

Showing 7 of 7 trials
NCT07479225Not ApplicableNot Yet RecruitingPrimary

Circulating Cell-Free DNA for Brain Abscess Diagnosis: A Pilot Study

NCT04938362RecruitingPrimary

Cognitive Function and Fatigue After Brain Abscess

NCT04140903Phase 4RecruitingPrimary

Partial Oral Antibiotic Treatment for Bacterial Brain Abscess

NCT02979951Recruiting

Fosfomycin I.v. for Treatment of Severely Infected Patients

NCT03418441Recruiting

Central Nervous System Infections in Denmark

NCT06242496UnknownPrimary

Brain Abscesses in Transplant Recipients: a Multicentre Retrospective Study (BAT-STUDY)

NCT04018742UnknownPrimary

MICROBIOLOGY OF CEREBRAL ABSCESSES

Showing all 7 trials

Research Network

Activity Timeline